Verteporfin with altered (delayed) light in occult CNV (VALIO) - Results of a phase II controlled clinical trial

被引：0
|
作者：
Slakter, JS
Rosenfeld, PJ
机构：
[1] Bascom Palmer Eye Inst, Miami, FL 33136 USA
[2] Vitreous Ret Mac Consult NY, New York, NY USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2003年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1101
引用
收藏
页码：U297 / U297
页数：1
相关论文
共 50 条
  • [41] Targeted treatment for fragile X syndrome: results of a randomized controlled phase II trial of arbaclofen
    Hagerman, Randi
    Rathmell, Barbara
    Wang, Lulu
    Carpenter, Randy
    Wang, Paul
    Berry-Kravis, Elizabeth
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2010, 54 : 884 - 884
  • [42] Neuroprotection with phenytoin in acute optic neuritis: results of a phase II randomised controlled trial.
    Raftopoulos, R.
    Hickman, S.
    Toosy, A.
    Sharrack, B.
    Mallik, S.
    Altmann, D.
    Malladi, P.
    Koltzenburg, M.
    Wheeler-Kingshott, C.
    Schmierer, K.
    Giovannoni, G.
    Miller, D.
    Kapoor, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 48 - 48
  • [43] Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trial
    Sanchorawala, Vaishali
    Patel, Jaymin M.
    Sloan, J. Mark
    Shelton, Anthony C.
    Zeldis, Jerome B.
    Seldin, David C.
    HAEMATOLOGICA, 2013, 98 (05) : 789 - 792
  • [44] A Bayesian adaptive Phase I-II clinical trial for evaluating efficacy and toxicity with delayed outcomes
    Koopmeiners, Joseph S.
    Modiano, Jaime
    CLINICAL TRIALS, 2014, 11 (01) : 38 - 48
  • [45] Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration:: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2
    Arnold, J
    Kilmartin, D
    Olson, J
    Neville, S
    Robinson, K
    Laird, A
    Richmond, C
    Farrow, A
    McKay, S
    McKechnie, R
    Evans, G
    Aaberg, TM
    Brower, J
    Waldron, R
    Loupe, D
    Gillman, J
    Myles, B
    Saperstein, DA
    Schachat, AP
    Bressler, NM
    Bressler, SB
    Nesbitt, P
    Porter, T
    Hawse, P
    Harnett, M
    Eager, A
    Belt, J
    Cain, D
    Emmert, D
    George, T
    Herring, M
    McDonald, J
    Mones, J
    Corcóstegui, B
    Gilbert, M
    Duran, N
    Sisquella, M
    Nolla, A
    Margalef, A
    Miller, JW
    Gragoudas, ES
    Lane, AM
    Emmanuel, N
    Holbrook, A
    Evans, C
    Lord, US
    Walsh, DK
    Callahan, CD
    DuBois, JL
    Moy, J
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 131 (05) : 541 - 560
  • [46] Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC clinical screening group
    Urosevic, V
    Chollet, P
    Adenis, A
    Chauvergne, J
    Fargeot, P
    Roche, H
    Kerbrat, P
    Lentz, MA
    Fumoleau, P
    Chevallier, B
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (01) : 181 - 182
  • [47] Endoscopic electroporation for inoperable oesophagogastric cancer: Preliminary results from a phase II clinical trial (The VECTOR Trial)
    Jackson, Andrew
    James, Eleanor
    Vohra, Ravinder
    Humes, David
    Parsons, Simon
    BRITISH JOURNAL OF SURGERY, 2022, 109
  • [48] Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma: Results of a Clinical Phase I/II Trial
    Yamanaka, Ryuya
    Homma, Junpei
    Yajima, Naoki
    Sano, Masakazu
    Takahashi, Masuhiro
    MOLECULAR THERAPY, 2006, 13 : S106 - S106
  • [49] Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: Results of a clinical phase I/II trial
    Yamanaka, R
    Homma, J
    Yajima, N
    Tsuchiya, N
    Sano, M
    Kobayashi, T
    Yoshida, S
    Abe, T
    Narita, M
    Takahashi, M
    Tanaka, R
    CLINICAL CANCER RESEARCH, 2005, 11 (11) : 4160 - 4167
  • [50] Clinical outcomes of the combination of bevacizumab and ttfields in patients with recurrent glioblastoma: Results of a phase II clinical trial.
    Fallah, Jaleh
    Chaudhary, Rekha T.
    Rogers, Lisa R.
    Wei, Wei
    Brewer, Cathy J.
    Peereboom, David M.
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345